Communicable Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
A "paradox of progress" shapes the social determinants of infectious diseases in Vietnam, 1975-2025.
Strategies for controlling communicable diseases in Afghanistan: a realist review.
Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications.
Identifying the climate sensitivity of infectious diseases: a conceptual framework.
Immunoengineering: An Emerging Field in Infectious Diseases.
Towards a 'people and nature' paradigm for biodiversity and infectious disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity, including 1 notable finding.
Research HighlightsView all 12Hide
- 2026-04-03A "paradox of progress" shapes the social determinants of infectious diseases in Vietnam, 1975-2025.Quan NK · 2026
- 2025-09-25Strategies for controlling communicable diseases in Afghanistan: a realist review.Hayat E · 2025
- 2025-08-12The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research.Ripa M · 2025
- 2025-08-06Current practices for assessing usability of novel point-of-care diagnostics for infectious diseases: a scoping review protocol.Castro MDM · 2025
- 2025-10-14From infectious diseases to chronic diseases: the paradigm shift of spatial epidemiology in disease prevention and control.Hu K · 2025
- 2025-08-27Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications.Kim T · 2025
- 2026-04-03ResearchA "paradox of progress" shapes the social determinants of infectious diseases in Vietnam, 1975-2025.Quan NK · 2026
- 2026-04-01ResearchWhose Line Is it Anyway? Defining Seropositivity Cutoffs for Infectious Disease Surveillance.White MT · 2026
- 2025-12-02ResearchAssociation between climatic conditions and infectious diseases: implications for Central Ethiopia region.Lambebo IH · 2025
- 2025-11-04ResearchGlobal perspectives on infectious diseases at risk of escalation and their drivers.Walker RJ · 2025
- 2025-10-14ResearchFrom infectious diseases to chronic diseases: the paradigm shift of spatial epidemiology in disease prevention and control.Hu K · 2025
- 2025-09-25ResearchStrategies for controlling communicable diseases in Afghanistan: a realist review.Hayat E · 2025
- 2025-09-24ResearchEpidemiological shifts in 23 acute infectious diseases in Southwest China (2005-2024): trends and implications for surveillance.Liu R · 2025
- 2025-09-24ResearchKeeping a modeling-driven public health dashboard relevant-lessons learned from the California Communicable diseases Assessment Tool.Thakur M · 2025
- 2025-08-27ResearchDiabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications.Kim T · 2025
- 2025-08-12ResearchThe INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research.Ripa M · 2025
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Communicable Diseases85
- COVID-1922
- Public Health8
- Disease Outbreaks6
- Climate Change5
- Communicable Disease Control5
- Developing Countries4
- Endocarditis4
Leading journals6
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America13
- Frontiers in immunology5
- Frontiers in public health5
- Emerging infectious diseases4
- PloS one4
- Scientific reports4
Leading researchers8
- Hoen B4
- Liu Y4
- Zhang Y4
- Duval X3
- Karchmer AW3
- Li Y3
- Selton-Suty C3
- Barrat A2
Affiliations (unnormalised)6
- School of Public Health9
- Instituto de Salud Carlos III3
- Northwestern University3
- School of Global Health3
- Université de Lorraine3
- Université Paris Cité3
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Communicable diseases are illnesses caused by infectious agents or their toxins that can be transmitted directly or indirectly from an infected person, animal, vector, or the environment to a susceptible host. The literature grounding frames them as a broad category spanning epidemiology, diagnosis, immunology, mortality, transmission, etiology, genetics, and therapy.
They are caused by infectious agents or the toxins they produce. Transmission can occur through direct or indirect spread from infected individuals, animals, vectors, or inanimate environmental sources.
The biological basis centers on host-pathogen interactions and the host immune response to infection. The grounding highlights innate and adaptive immunity, cytokine signaling, and cytokine storm as important mechanisms in some infectious diseases, along with the role of host gene expression and immune maturation across the lifespan.
Risk is increased by exposure to infected individuals, animals, vectors, or contaminated environmental sources. The grounding also supports increased susceptibility with immature immune function in infancy and declining immune function in old age, as well as impaired immunity associated with protein or amino acid deficiency.
Management is described at the level of diagnosis, drug therapy, and therapy rather than for a single disease entity. The grounding supports infectious-disease diagnosis using clinical metagenomics and treatment approaches that include antimicrobial or other drug therapy, with vaccines represented by COVID-19 vaccines and synthetic vaccine platforms in the literature.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.